
Board of Directors
The Board of Humana shall consist of three to eight members according to the articles of association. Members of the Board shall together possess key skills and experience to ensure Humana’s optimum development.
Board of Directors

Anders Nyberg
Chairman of the board
Education
Studied Business Administration and Economics at Stockholm University.
Other current appointments
Chairperson, Gordon delivery; Board member, Apopro (Denmark) and Centrofarm (Italy).
Previous appointments and professional experience
CEO of Apotek Hjärtat, vice President of ICA and Axfood.
Holdings per 2023-02-14
Own and closely associated holdings - 28,000 shares, 10,000 synthetic options
Independent of the company and its executive management, as well as of major shareholders in the company.

Grethe Aasved
Board memberBorn 1954. Board member since 2023. Member of the remuneration committee.
Education
Medical Doctor from Oslo University, Specialist in Psychiatry
Other ongoing assignments
CEO of St. Olavs Hospital, University Hospital in Trondheim. Advisory Board Member of Health technology, Det Norske Veritas (DNV). Chairman of the Board, Faculty of Medicine and Health Sciences, the Norwegian University of Science and Technology (NTNU). Board member of HEMIT HF and Board member of Kavli Institute for Systems Neuroscience.
Previous assignments and professional experience
Board member of Unicare Holding, Pfizer (Norway) and Tomra Systems. Chairman of the Board of the Norwegian Junior Doctors Association, Vice President of the Norwegian Medical Association, Secretary General of the European organisation of Doctors, Brussels, CEO of Norway in Aleris Helse, Director Governmental Affairs at Pfizer (Norway)
Holdings per 2023-05-09
Own and close related parties holdings: 0 shares.
Independent in relation to Humana, the senior management and Humana’s major shareholders.

Monica Lingegård
Board memberEducation
M.Sc.Econ, University of Stockholm.
Other current appointments
CEO of SJ. Chairman of Swedish Space Corporation Group.
Previous appointments and professional experience
CEO of Samhall and of G4S Secure Solutions. Board member of Nobina, Wireless Maingate, Swedish International Development Cooperation Agency (Sida), Orio, Svenskt Näringsliv and Almega.
Holdings per 2020-12-31
Own and close related parties holdings - 1,500 shares, 10,000 synthetic options
Independent in relation to Humana, the senior management and Humana’s major shareholders.

Leena Munter-Ollus
Board memberBorn 1968. Board member since 2023. Member of the audit committee.
Education
M. Sc. In International Accounting from the Swedish School of Economics in Helsinki.
Other ongoing assignments: Interim Head of Transformation at Business Finland. Starting as CEO at Taitotalo. Board member at Työkanava. Chairman of the Supervisory Board co-operative Varuboden – Osla.
Previous assignments and professional experience
CEO of Haltija Group, Mainio Vire and ManpowerGroup Finland. Leading positions at Manpower and 3M. Board member at Sailab Medtech Finland and Kaisankoti.
Holdings per 2023-05-09
Own and close related parties holdings: 0 shares.
Independent in relation to Humana, the senior management and Humana’s major shareholders.

Carolina Oscarius Dahl
Board memberBorn 1983. Board member since 2023. Member of the remuneration committee.
Education
M.Sc. in Business and Economics from the Stockholm School of Economics.
Other ongoing assignments: Partner at Impilo.
Previous assignments and professional experience
Investment Director at Interogo Holding, Investment Manager at Nordstjernan and Associate Principal at McKinsey & Company.
Holdings per 2023-05-09
Own and close related parties holdings: 0 shares.
Independent of the company and its executive management, however he is considered to have a connection with one of the major shareholders in the company.

Ralph Riber
Board memberBorn 1958. Board member since 2023. Member of the audit committee.
Education
Bachelor’s degree in economics and M.Sc. in Business Administration from the University of Gothenburg
Other ongoing assignments
CEO at Atveda. Consultant at Riber Enterprises. Board member at Stockholms Stadsmission and the school foundation of Stadsmissionen.
Previous assignments and professional experience
CEO of Internationella Engelska Skolan and Ambea. Vice President Consulting of Adacra. CEO of Tärno Kompani. Board member at Fenix Funeral, Esperi Care Group, Aleris and Internationella Engelska Skolan.
Holdings per 2023-05-09
Own and close related parties holdings - 10,000 shares.
Independent in relation to Humana, the senior management and Humana’s major shareholders.

Fredrik Strömholm
Board memberM.Sc. in Economics from the Stockholm School of Economics, with a major in finance at the Ecole des Hautes Etudes Commerciales in France; and studies in French, Russian and East European history at the universities of Uppsala and Stockholm.
Co-founder of Impilo and chairman of its investment committee, board member of Ferrosan Medical Devices, Ortic 3D, the Fertility Partnership and Euro Accident. He is also chairman of Natur and Kultur and board member of the college board of The Swedish School of Sport and Health Sciences (GIH) and Skellefteå AIK Hockey.
Previous appointments and professional experience
Partner and founder at Altor Equity Partners for 14 years, managing director at Goldman Sachs International and investment manager at Nordic Capital.
Holdings per 2022-09-09
Own and closely associated holdings - 12,226,164 shares
Independent of the company and its executive management, however he is considered to have a connection with one of the major shareholders in the company.
The work of the Board
The Board of Humana has overall responsibility for building a valuecreating and sustainable business for shareholders with continuity and a long-term perspective. The Board is responsible for the Company’s overall strategy, ensuring well-informed decision-making processes and maintaining a clear perception of trends in the sector and Humana’s business environment. Another important function of the Board is to ensure that the company has good risk management, control and business monitoring.
The Board’s duties and responsibilities are regulated by the Swedish Companies Act and Humana’s Articles of Association. The Board’s work is also governed by annually defined rules of procedure, which describe areas such as the division of duties and responsibility between Board members, the Chairman and the CEO. The Board also draws up instructions for the Board’s committees. The Board of
Humana continuously monitors strategic direction, economic development and the Company’s methods and processes in order to maintain well-functioning operations. Humana’s Board is also responsible for ensuring good quality financial reporting and internal control and evaluating the business in relation to the goals and guidelines defined by the Board. The Chairman of the Board and the CEO are responsible for monitoring the Company’s development, and for preparing and leading Board meetings. The Chairman is also responsible for ensuring that Board members conduct an annual evaluation of their work and that they receive the information they need to perform their duties effectively and satisfactorily
The work of the board in 2022
Read about the Board's work during the latest reported year in the Corporate Governance Report, which is part of Humana's Annual Report.
Audit Committee
In accordance with the Code and the Companies Act, the Board of Directors of Humana has established from among its members an Audit committee. The Audit Committee’s main task is to support the Board in fulfilling its responsibilities in the areas of financial reporting, accounting, auditing, internal control and risk management. The Audit Committee works according to rules of procedure defined by the Board. The Committee’s duties also include reviewing internal audit procedures, and scrutinising and monitoring the auditor’s impartiality and independence. The Audit Committee has regular meetings with the auditors in order to keep informed about the focus and scope of the audit and observations arising from the audit.
Audit Committee members:
- Fredrik Strömholm, Chair
- Anders Nyberg
- Leena Munter
- Ralph Riber
The Chair of the Committee, Fredrik Strömholm, has the accounting expertise required by the Swedish Companies Act. All members of the Committee are independent of the Company. Anders Nyberg, Leena Munter and Ralph Riber are independent of the Company’s largest owner; Fredrik Strömholm is not.
Remuneration Committee
In accordance with the Code and the Companies Act, the Board of Directors of Humana has established from among its members a Remuneration Committee. The Remuneration Committee works in accordance with rules of procedure adopted by the Board of Directors. The Remuneration Committee’s main tasks are to submit proposals to the Board on remuneration and conditions of employment for the President and CEO, and remuneration policies for Group management, and to monitor and evaluate current and completed incentive programmes. The Committee also makes decisions on remuneration and conditions of employment for other members of Group management. Remuneration Committee members are also responsible for monitoring and evaluating application of the guidelines for remuneration of senior executives adopted by the AGM. The Committee is also responsible for succession planning and talent management.
Remuneration Committee members:
- Anders Nyberg, Chair
- Monica Lingegård
- Grethe Aasved
- Carolina Oscarius Dahl
All members are independent of the Company and its management.
Remuneration
Board diversity policy
As a group, members of Humana’s Board should have the right expertise, experience and background to contribute to the Company’s development. The aim is for the Board to consist of members of varying ages, with both male and female representation, from varied geographical and ethnic backgrounds and complementing each other in terms of educational and professional backgrounds. The objective is for the Board to contribute independent and critical challenges.
The Board has adopted a diversity policy, which the Nomination Committee considers in the preparation of its proposal for the AGM. The Nomination Committee also bases its work on Section 4.1 of the Swedish Corporate Governance Code.